APR Corp. maintains its history of record-breaking financial performance also in Q3 2025, anticipating exceeding KRW 1 trillion revenue by the end of the year
Q3 2025; revenue KRW 385.9 bn while Operating Profit KRW 96.1 bn, according to Provisional performance based on consolidation. A new quarter financial record compared to the same period last year, 122% increased revenue, 253% increased operating...
Maypharm Unveils Revolutionary Hybrid Filler, Hyalmass Aqua-Exosome: The Future of Skin Hydration and Regeneration
Introducing Hyaluronic Acid, Exosomes, and PDRN SEOUL, South Korea, Dec. 30, 2024 /PRNewswire/ -- Maypharm Co., Ltd., a leading innovator in medical and dermo-cosmetic products, proudly introduces the global launch of Hyalmass Aqua-Exosome, a...